Results 151 to 160 of about 20,420 (285)

Efficacy and safety of once‐weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT‐2 trial

Diabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4557-4566, August 2025.
Abstract Aim To assess the efficacy and safety of once‐weekly tirzepatide in Japanese participants with obesity and type 2 diabetes (T2D). Materials and Methods This subpopulation analysis of 41 Japanese participants from three clinical trial sites in the SURMOUNT‐2 trial evaluated the efficacy and safety of tirzepatide as an adjunct to lifestyle ...
Toshimasa Yamauchi, Taro Asakura, Tomotaka Shingaki, Tomonori Oura, Hideki Katagiri   +4 more
wiley   +1 more source

Dangers of biguanides [PDF]

Practical Diabetes International, 1986
openaire   +2 more sources

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study

Diabetes/Metabolism Research and Reviews, Volume 41, Issue 5, July 2025.
ABSTRACT Aims Type 2 diabetes mellitus (T2DM) is recognized for increasing the risk of dementia; however, conclusive evidence supporting interventions to mitigate this risk remains elusive. This study endeavours to ascertain whether the glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) correlate with reduced incidence of dementia.
Hung‐Wen Cheng, Shun‐Fa Yang, Pei‐Lun Liao, Chiu‐Hsian Lee, Gwo‐Ping Jong   +4 more
wiley   +1 more source

Studies in Copper(ll) Chelates: Part I. α, α'=Dipyridyl Mono- (biguanide) Copper(II) and o-Phenanthroline Mono(biguaoide) Copper(II) Complexes [PDF]

, 1968
R. L. Dutta, Dhrubananda De, A. Syamal
openalex   +1 more source

Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP‐1 Receptor Agonists: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 8, Issue 4, July 2025.
GLP‐1RA use in T2DM may reduce risk of glaucoma: A meta‐analysis and systematic review. ABSTRACT Aims Glaucoma, a leading cause of irreversible blindness, is particularly prevalent among individuals with Type 2 Diabetes Mellitus (T2DM), a known risk factor for the disease.
Maheen Asif, Aliza Asif, Ummi Aiman Rahman, Hanzala Ahmed Farooqi, Oshaz Fatima, Waqar Ali, Uzair Jafar, Mohammed Hammad Jaber   +7 more
wiley   +1 more source

Mixed-Ligand Complexes : Part VI. Acetoacetanilidato bis (Biguanide) Cobalt (III), N-Benzoylphenylhydroxylaminato bis (Biguanide) Cobalt (III) and 2-Picolylamine bis (Biguanide) Cobalt (III) Salts [PDF]

, 1968
R. L. Dutta, Kallol Kumar Bhattacharyya
openalex   +1 more source

An Updated Systematic Review and Meta‐Analysis on the Efficacy and Safety of Metformin as Add‐on Therapy to Insulin in Patients With Type 1 Diabetes

Endocrinology, Diabetes &Metabolism, Volume 8, Issue 4, July 2025.
This updated meta‐analysis evaluates the efficacy and safety of metformin as add‐on therapy to insulin in patients with type 1 diabetes. The results show reductions in HbA1c, BMI, and insulin dose in both adolescents and adults, alongside improved lipid profiles.
Mohammad Mahdi Masouri, Rasoul Ebrahimi, Shokoofe Noori   +2 more
wiley   +1 more source

Mixed Ligand Complexes : Part I. O-phenanthroline Bis Biguanide Cobalt (III) and αα'-Dipyridyl Bis Biguanide Cobalt (III) Salts [PDF]

, 1967
R. L. Dutta, S. Sarkar
openalex   +1 more source

Treated mothers, troubled hearts: cardiovascular trade‐offs of metformin use in pregnancy

The Journal of Physiology, EarlyView.
Clare M. Reynolds
wiley   +1 more source

Care solution effects on contact lens in vivo wettability [PDF]

, 2017
Abusharha, Ali A., Fagehi, Raied, Oliver, Katherine, Pearce, E. Ian, Tomlinson, Alan   +4 more
core   +2 more sources